The CRISPR/Cas9 screening in chemo-resistant small-cell lung cancer (SCLC) identified serine/threonine kinase cell division cycle 7 (CDC7) as a potential synergistic target. The gene discussed is CDC7; the disease is small cell lung carcinoma.